Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -58,574 | 130,133 | -120,548 | -122,993 | -131,445 |
| Depreciation Amortization | 3,947 | 5,119 | 5,019 | 3,998 | 2,583 |
| Income taxes - deferred | N/A | -6,014 | N/A | -12,661 | N/A |
| Accounts receivable | 53,227 | -50,608 | -1,099 | 166 | -4,080 |
| Accounts payable and accrued liabilities | -20,969 | 20,097 | -19,913 | -11,875 | 13,584 |
| Other Working Capital | 31,079 | -58,287 | -44,774 | -65,314 | -53,531 |
| Other Operating Activity | -151,679 | 73,367 | 32,708 | 23,285 | -2,739 |
| Operating Cash Flow | $-142,969 | $113,807 | $-148,607 | $-185,394 | $-175,628 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 268,000 | -155,785 | 169,671 | 50,750 | 18,483 |
| PPE Investments | 10,926 | -70 | -95 | -228 | -231 |
| Purchase Of Investment | -58,555 | N/A | N/A | N/A | N/A |
| Sale Of Investment | 160,385 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $380,756 | $-155,855 | $169,576 | $50,522 | $18,252 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 12,529 | 145,905 | N/A |
| Debt Repayment | -216,580 | -1,285 | -14,533 | -2,280 | -2,016 |
| Common Stock Issued | 69,970 | N/A | 732 | 7,987 | 3,624 |
| Common Stock Repurchased | -1,026 | -941 | -972 | -1,679 | -621 |
| Financing Cash Flow | $-147,636 | $-2,226 | $-2,244 | $149,933 | $987 |
| Beginning Cash Position | 36,112 | 80,386 | 61,661 | 46,600 | 202,989 |
| End Cash Position | 126,263 | 36,112 | 80,386 | 61,661 | 46,600 |
| Net Cash Flow | $90,151 | $-44,274 | $18,725 | $15,061 | $-156,389 |
| Free Cash Flow | |||||
| Operating Cash Flow | -142,969 | 113,807 | -148,607 | -185,394 | -175,628 |
| Capital Expenditure | -87 | -70 | -95 | -228 | -231 |
| Free Cash Flow | -143,056 | 113,737 | -148,702 | -185,622 | -175,859 |